Zobrazeno 1 - 10
of 19
pro vyhledávání: '"Lars Boukharta"'
Publikováno v:
PLoS Computational Biology, Vol 10, Iss 4, p e1003585 (2014)
Site-directed mutagenesis combined with binding affinity measurements is widely used to probe the nature of ligand interactions with GPCRs. Such experiments, as well as structure-activity relationships for series of ligands, are usually interpreted w
Externí odkaz:
https://doaj.org/article/ad9c8b7c7b9a4a5eb841bf423e044df6
Autor:
Lionel Trésaugues, Kilian Huber, Ioanna Panagakou, Camilla Silvander, F. Rahm, Martin Andersson, Antoine Talagas, Oleg Fedorov, Marcus Bauser, Tobias Ginman, L. Diaz-Saez, Ellermann Manuel, Kenth Hallberg, Rickard Forsblom, Johan Lindström, Mátyás Gorjánácz, Anja Giese, Judith Günther, Lars Boukharta Persson, P. Siejka, Jenny Viklund, Ulrika Ericsson
Publikováno v:
Journal of Medicinal Chemistry. 61(6)
Recent literature has both suggested and questioned MTH1 as a novel cancer target. BAY-707 was just published as a target validation small molecule probe for assessing the effects of pharmacological inhibition of MTH1 on tumor cell survival, both in
Publikováno v:
Journal of Chemical Information and Modeling. 54:1488-1499
Cyclooxygenase-1 (COX-1) is one of the main targets of most pain-relieving pharmaceuticals. Although the enzyme is well characterized, it is known to be a difficult target for automated molecular docking and scoring. We collected from the literature
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Anna Stary-Weinzinger, Bert L. de Groot, Göran Wallin, Johan Åqvist, Lars Boukharta, Henrik Keränen
Publikováno v:
Biochemistry
The hERG potassium channel is of major pharmaceutical importance, and its blockade by various compounds, potentially causing serious cardiac side effects, is a major problem in drug development. Despite the large amounts of existing biochemical data
Autor:
Lewis C. Cantley, Albert S. Yu, Kannan Karukarichi, Fredrik Karlsson, Ellen Santangelo, Rui Wang, F. Rahm, Ulrika Ericsson, Johan Linstrom, Mariell Pettersson, Jessica Martinsson, Tiago Braga, Madeleine Livendahl, Aine Brigette Henley, Horst Wähling, Lars Boukharta Persson, Martin Andersson, Tobias Ginman, Andreas Hoglund, Parisa Zolfaghari, Rickard Forsblom, Jenny Viklund, Lionel Trésaugues, David L. McElligott, Hyeseok Shim, Antoine Talagas, Tommy Johansson, Kesicki Edward A
Publikováno v:
Blood. 132:213-213
Phosphoinositide signaling is central to many cellular processes including the cell survival pathway known as autophagy. While there is evidence that autophagy can suppress tumorigenesis under certain circumstances, there is increasingly abundant evi
Autor:
Hugo Gutiérrez-de-Terán, Helena Åkerberg, Dan Larhammar, Ingrid Lundell, Helena Fällmar, Lars Boukharta, Paula Sjödin, Nina Mohell
Publikováno v:
Regulatory Peptides. 163:120-129
Neuropeptide Y (NPY) and peptide YY (PYY) share approximately 70% of their 36 amino acids and bind to the same three human receptor subtypes, Y1, Y2 and Y5, even though these receptors only share approximately 30% sequence identity. Based on our prev
Publikováno v:
Biochemistry. 48:1743-1753
Horizontal DNA transfer between bacteria is widespread and a major cause of antibiotic resistance. For logistic reasons, single or combined genes are shuttled between vectors such as plasmids and bacterial chromosomes. Special elements termed integro
Publikováno v:
Journal of Medicinal Chemistry. 51:2657-2667
To produce reliable predictions of bioactive conformations is a major challenge in the field of structure-based inhibitor design and is a requirement for accurate binding free energy predictions with structure-based methods. A series of HIV-1 reverse
Publikováno v:
Journal of Medicinal Chemistry. 51:2648-2656
Docking, scoring, molecular dynamics (MD), and the linear interaction energy (LIE) method are used here to predict binding modes and affinities for a set of 43 non-nucleoside inhibitors to HIV-1 reverse transcriptase. Starting from a crystallographic